Advaxis Inc (ADXS)

NASDAQ
0.3658
-0.0344(-8.60%)
  • Volume:
    2,728,628
  • Bid/Ask:
    0.3652/0.3672
  • Day's Range:
    0.3650 - 0.4050

ADXS Overview

Prev. Close
0.4002
Day's Range
0.365-0.405
Revenue
3.24M
Open
0.4
52 wk Range
0.291-1.57
EPS
-0.2
Volume
2,728,628
Market Cap
53.23M
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
6,744,226
P/E Ratio
-
Beta
2.19
1-Year Change
40.42%
Shares Outstanding
145,638,459
Next Earnings Date
Jan 24, 2022
What is your sentiment on Advaxis Inc?
or
Vote to see community's results!

Advaxis Inc Company Profile

Employees
18

Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for the treatment of prostate cancer. It is also conducting clinical studies of Lm Technology immunotherapies in the following areas of disease focused hotspot/off-the-shelf neoantigen-directed therapies; human papilloma virus-associated cancers; and prostate cancer. The company has collaborations and partnerships with Merck & Co., Inc.; OS Therapies, LLC; Aratana Therapeutics Inc.; Biocon Limited; Global BioPharma Inc.; Knight Therapeutics Inc; and others. Advaxis, Inc. was founded in 2002 and is based in Monmouth Junction, New Jersey.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellStrong SellStrong SellStrong Sell
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Sell
SummaryStrong SellStrong SellStrong SellStrong SellStrong Sell
  • looks like they have to resplit atleast 10:1 and than plummet again
    0
    • buy ONE it's gonna explode
      0
      • https://invst.ly/w2bgu ... Practically ready 👀
        0
        • Biosight's Aspacytarabine will be a huge success. Blockbuster drug. Mark my word.
          0
          • When this will be approved
            0
        • whats going on this stock?premarket $6??
          1
          • something is wrong about the website :)
            0
          • maybe reverse split?
            0
          • hha i wish it was real...but something is wrong with the website as this is not the only stock showing wrong market price.
            0
        • today must be green and up to 0.75 at least
          0
          • just wait it will be better nearly it's super merge
            0
            • target price today guys???
              0
              • 4 me : 0.44 would be great
                0
            • to the moon 🌙🌙🌙🌙
              1
              • Advaxis and Biosight Announce Entry into Definitive Merger Agreement
                0
                • I almost sold last week because of the news. Whew!!!
                  0
                  • Could be delisted from Nasdaq. Should I sell?
                    1
                    • not now...50..60 bucks easy
                      2
                    • not now...50..60 bucks easy
                      1
                    • Do your research. This isn't getting delisted.
                      0
                  • Acasti Pharma Inc (ACST) seems to show a simular trading pattern as (ADXS) and also seems to run on Reddit fuel. Might be worth looking into.
                    0
                    • Bought some Acasti yesterday...am waiting to buy this one too
                      0
                  • Told you it will drop ... learn to listen and take heed when a guru is speaking
                    1
                    • No agurment from me.
                      0
                    • I also took profit. But altough you were correct, being humble about it would suit you better.
                      0
                  • This will plummet after hours or before next week. Cash out while you can
                    1
                    • Scott Pricewhat news
                      0
                    • New was wrong choice of words. More of a positive artical from seeking ALPH
                      1
                    • Scott Priceah ok, thanks
                      0
                  • Whats if everyones price target on this. Charts look great
                    0
                    • Up 37% ... taking profits
                      1
                      • I believe this company is working on something big. I'm waiting patiently. talk in a few years
                        0
                        • A few years ... impressive
                          1
                        • Kah Carterhodl path to wealth
                          0
                      • Buy buy buy
                        1
                        • sell sell sell
                          9
                          • 10-15th April is the conference for Cancer.. ADXS will be with them for presentation.. Be ready to collect before 10th April..
                            0
                            • 🚀🚀🚀🚀🚀🚀🚀🙏
                              0
                              • Loaded extra on 0,98
                                0
                                • Bought 2000 shares at $0.96, gonna moon
                                  1
                                  • Its going to go up in a few days i think
                                    0
                                    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.